Edwards Lifesciences Corp (EW)

Currency in USD
80.00
+4.20(+5.54%)
Closed·
After Hours
79.86-0.14(-0.18%)
·

EW Financial Summary

Key Ratios

P/E Ratio32.36
Price/Book4.47
Debt / Equity6.86%
Return on Equity16.51%
Dividend Yield0.00%
EBITDA1.64B
Fair ValueUnlock
Fair Value UpsideUnlock

Statements Highlights

Period Ending:
2015
31/12
2016
31/12
2017
31/12
2018
31/12
2019
31/12
2020
31/12
2021
31/12
2022
31/12
2023
31/12
2024
31/12
* In Millions of USD (except for per share items)

Analyst Ratings

16 Buy
17 Hold
1 Sell
Ratings:
34 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 81.99
(+2.49% Upside)

Earnings

Latest Release
Jul 24, 2025
EPS / Forecast
0.67 / 0.62
Revenue / Forecast
1.53B / 1.49B
EPS Revisions
Last 90 days

FAQ

What were Edwards Lifesciences's earnings for the latest quarter?

The Edwards Lifesciences EPS (TTM) is 7.03. Edwards Lifesciences reported sales of 1,412.70, net income of 358.00, and EPS of 0.67 for the latest quarter.

What was Edwards Lifesciences's net income for the latest quarter?

Edwards Lifesciences's net income for the latest quarter was 358.00.

How did Edwards Lifesciences's performance compare year-over-year in the latest quarter?

The company's revenue moved from 1,385.80 in the previous quarter to 1,412.70 in the latest quarter, and net income moved from 385.60 to 358.00 compared to the previous quarter.

What is Edwards Lifesciences's net profit margin on a TTM basis?

Edwards Lifesciences's trailing twelve months (TTM) net profit margin is 76.75%.

How does Edwards Lifesciences's debt to equity ratio compare to industry standards?

Edwards Lifesciences's total debt-to-equity ratio is 6.86%.

What is Edwards Lifesciences's return on investment on a TTM basis?

Edwards Lifesciences's trailing twelve months (TTM) return on investment (ROI) is 16.51%.

Did Edwards Lifesciences gain or lose cash last quarter?

In the latest quarter, Edwards Lifesciences's net change in cash was 90.00 million.

What were Edwards Lifesciences's total assets and liabilities in the latest quarter?

As of the latest quarter, Edwards Lifesciences reported total assets of 13,022.30 million and total liabilities of 1,394.80 million.

How has Edwards Lifesciences's total revenue grown this year?

Edwards Lifesciences's total revenue was 1,385.80 in the previous quarter and 1,412.70 in the latest quarter.

What is Edwards Lifesciences's gross margin on a TTM basis?

Edwards Lifesciences's trailing twelve months (TTM) gross margin is 78.87%.

What was Edwards Lifesciences's revenue per share for the latest quarter?

Edwards Lifesciences's revenue per share for the latest quarter was 31.41.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.